Interleukin 10 (IL-10) is a novel lymphokine which exhibits strong DNA
and amino-acid sequence homology to BCRF1, an open reading frame in t
he Epstein-Barr virus genome. Using a wide panel of EBV positive and E
BV negative cell lines, it has been shown that EBV positive B cell lin
es derived from patients with AIDS and Burkitt's lymphoma (AABCL) secr
ete large quantities of B cell IL-10, compared-with EBV-positive B cel
l lines obtained from patients with undifferentiated lymphomas of Burk
itt's and non-Burkitt's types. In contrast, EBV-negative B cell lines
do not express IL-10 by Northern blot analysis, ELISA or even PCR. B c
ell IL-10 is confined to a narrow window in the B cell differentiation
pathway, and whereas IL-10 expression is detected in mature and prepl
asmacytic stages, none of the pro-B, pre-B, or myeloma cell lines prod
uce IL-10. EBV exerts direct effect on the production of B cell IL-10,
and purified tonsillar B cells infected with EBV were triggered to se
crete IL-10. The large amount of IL-10 secreted by B cells derived fro
m AIDS-related lymphomas suggests that HIV-1 also exerts direct effect
on IL-10 secretion. B cell IL-10 may function as autocrine growth fac
tor for B cell lymphomas, and both IL-10 and BCRFI seem to be involved
in the pathophysiology of non-Hodgkin's lymphomas.